Literature DB >> 23260142

Crystal structure of the HLA-DM-HLA-DR1 complex defines mechanisms for rapid peptide selection.

Wouter Pos1, Dhruv K Sethi, Melissa J Call, Monika-Sarah E D Schulze, Anne-Kathrin Anders, Jason Pyrdol, Kai W Wucherpfennig.   

Abstract

HLA-DR molecules bind microbial peptides in an endosomal compartment and present them on the cell surface for CD4 T cell surveillance. HLA-DM plays a critical role in the endosomal peptide selection process. The structure of the HLA-DM-HLA-DR complex shows major rearrangements of the HLA-DR peptide-binding groove. Flipping of a tryptophan away from the HLA-DR1 P1 pocket enables major conformational changes that position hydrophobic HLA-DR residues into the P1 pocket. These conformational changes accelerate peptide dissociation and stabilize the empty HLA-DR peptide-binding groove. Initially, incoming peptides have access to only part of the HLA-DR groove and need to compete with HLA-DR residues for access to the P2 site and the hydrophobic P1 pocket. This energetic barrier creates a rapid and stringent selection process for the highest-affinity binders. Insertion of peptide residues into the P2 and P1 sites reverses the conformational changes, terminating selection through DM dissociation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23260142      PMCID: PMC3530167          DOI: 10.1016/j.cell.2012.11.025

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  59 in total

1.  HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides.

Authors:  J M Riberdy; J R Newcomb; M J Surman; J A Barbosa; P Cresswell
Journal:  Nature       Date:  1992-12-03       Impact factor: 49.962

2.  Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules.

Authors:  P A Roche; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

3.  MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding.

Authors:  R N Germain; L R Hendrix
Journal:  Nature       Date:  1991-09-12       Impact factor: 49.962

4.  Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding.

Authors:  P A Roche; P Cresswell
Journal:  Nature       Date:  1990-06-14       Impact factor: 49.962

5.  Structure of the human class I histocompatibility antigen, HLA-A2.

Authors:  P J Bjorkman; M A Saper; B Samraoui; W S Bennett; J L Strominger; D C Wiley
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

6.  Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules.

Authors:  R N Germain; A G Rinker
Journal:  Nature       Date:  1993-06-24       Impact factor: 49.962

7.  Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

Authors:  J H Brown; T S Jardetzky; J C Gorga; L J Stern; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1993-07-01       Impact factor: 49.962

8.  Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding.

Authors:  T S Jardetzky; J C Gorga; R Busch; J Rothbard; J L Strominger; D C Wiley
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

9.  Sortase-mediated protein ligation: a new method for protein engineering.

Authors:  Hongyuan Mao; Scott A Hart; Amy Schink; Brian A Pollok
Journal:  J Am Chem Soc       Date:  2004-03-10       Impact factor: 15.419

10.  pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule.

Authors:  P A Reay; D A Wettstein; M M Davis
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

View more
  79 in total

1.  Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides.

Authors:  Zemin Zhou; Eduardo Reyes-Vargas; Hernando Escobar; Brant Rudd; Alan L Rockwood; Julio C Delgado; Xiao He; Peter E Jensen
Journal:  Eur J Immunol       Date:  2016-01-22       Impact factor: 5.532

2.  HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis.

Authors:  Roberto Meza-Romero; Gil Benedek; Xiaolin Yu; Jeffery L Mooney; Rony Dahan; Nerri Duvshani; Richard Bucala; Halina Offner; Yoram Reiter; Gregory G Burrows; Arthur A Vandenbark
Journal:  J Immunol       Date:  2014-03-28       Impact factor: 5.422

Review 3.  A peptide's perspective on antigen presentation to the immune system.

Authors:  Jacques Neefjes; Huib Ovaa
Journal:  Nat Chem Biol       Date:  2013-12       Impact factor: 15.040

4.  Single-molecule motions of MHC class II rely on bound peptides.

Authors:  Haruo Kozono; Yufuku Matsushita; Naoki Ogawa; Yuko Kozono; Toshihiro Miyabe; Hiroshi Sekiguchi; Kouhei Ichiyanagi; Noriaki Okimoto; Makoto Taiji; Osami Kanagawa; Yuji C Sasaki
Journal:  Biophys J       Date:  2015-01-20       Impact factor: 4.033

5.  A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  J Immunol Methods       Date:  2014-02-25       Impact factor: 2.303

6.  Patient HLA Germline Variation and Transplant Survivorship.

Authors:  Effie W Petersdorf; Philip Stevenson; Mari Malkki; Roland K Strong; Stephen R Spellman; Michael D Haagenson; Mary M Horowitz; Ted Gooley; Tao Wang
Journal:  J Clin Oncol       Date:  2018-06-14       Impact factor: 44.544

Review 7.  Selection of immunodominant epitopes during antigen processing is hierarchical.

Authors:  Scheherazade Sadegh-Nasseri; AeRyon Kim
Journal:  Mol Immunol       Date:  2018-08-24       Impact factor: 4.407

8.  DNA prime-protein boost vaccine encoding HLA-A2, HLA-A24 and HLA-DR1 restricted epitopes of CaNA2 against visceral leishmaniasis.

Authors:  Jinlei He; Fan Huang; Jianhui Zhang; Han Chen; Qiwei Chen; Junrong Zhang; Jiao Li; Zhiwan Zheng; Dali Chen; Jianping Chen
Journal:  Immunology       Date:  2018-10-24       Impact factor: 7.397

Review 9.  HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation.

Authors:  Elizabeth D Mellins; Lawrence J Stern
Journal:  Curr Opin Immunol       Date:  2013-12-08       Impact factor: 7.486

10.  The MHC class II cofactor HLA-DM interacts with Ig in B cells.

Authors:  Henriette Macmillan; Michael J Strohman; Sashi Ayyangar; Wei Jiang; Narendiran Rajasekaran; Armin Spura; Ann J Hessell; Anne-Marie Madec; Elizabeth D Mellins
Journal:  J Immunol       Date:  2014-08-06       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.